论文部分内容阅读
血活素注射液是从新生幼牛中经高新生物技术提取的多肽类活性物质制备而成。本品可显著增强组织细胞对氧及葡萄糖的摄取和利用,可迅速改善细胞缺氧状态及机体内环境,增加心、脑、肝等脏器的血流量,改善微循环,改善红细胞变形能力,抑制血小板聚集,降低血粘稠度,促进肝细胞生长,促进创伤愈合炎症恢复;可诱生干扰素及白介素,增强机体NK和LAK细胞活性,提高机体免疫能力。临床主要用于治疗各种脑循环,脑代谢障碍,如脑中风、颅脑外伤、脑栓塞、脑出血、脑动脉硬化、老年痴呆等。最近发现本品引起过敏反应
Blood injection of live newborn cow from the high-tech biotechnology extracted peptides prepared from active substances. This product can significantly enhance the organization of oxygen and glucose uptake and utilization, can rapidly improve cell hypoxia and the body environment, increase heart, brain, liver and other organs of blood flow, improve microcirculation and improve the ability of red cell deformability, Inhibit platelet aggregation, reduce blood viscosity, promote liver cell growth and promote wound healing inflammation recovery; can induce interferon and interleukin, enhance the activity of NK and LAK cells, and enhance immunity. Clinical mainly for the treatment of various cerebral circulation, cerebral metabolic disorders, such as stroke, craniocerebral trauma, cerebral embolism, cerebral hemorrhage, cerebral arteriosclerosis, Alzheimer’s and so on. Recently found that the product caused an allergic reaction